(Boursier.com) — Genomic Vision issued the 3rd tranche of bonds convertible into shares with share subscription warrants (OCABSA) for a net amount of 1.92 million euros.
On June 23, Genomic Vision’s management board decided to issue 2,000,000 OCABSAs for the benefit of Winance with a nominal value of 2 million euros, subscribed for a total net amount of 1.92 ME. , as well as 525,000 bonds convertible into shares delivered in payment of the third quarter of the Investor’s commitment fee. The OCABSA subscription price was released in several installments, the last part of which was on June 23.
The gross product of this second tranche is 2 ME and the net product 1.92 ME.
The company also confirms its intention to continue its investments in order to carry out its strategic plan and it will soon draw a new tranche of financing by issuing 2,000,000 OCABSAs which will be subscribed by the investor subject to the fulfillment of the conditions set out in the financing program.
©2023 Boursier.com